These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38415671)

  • 21. The New "Opioid Crisis": Scientific Bias, Media Attention, and Potential Harms for Patients with Refractory Dyspnea.
    Rocker G; Bourbeau J; Downar J
    J Palliat Med; 2018 Feb; 21(2):120-122. PubMed ID: 29393775
    [No Abstract]   [Full Text] [Related]  

  • 22. Attitudes of patients with chronic breathlessness towards treatment with opioids.
    Verberkt CA; van den Beuken-van Everdingen MHJ; Wouters EFM; Janssen DJA
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31699842
    [No Abstract]   [Full Text] [Related]  

  • 23. Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Vozoris NT
    Am J Respir Crit Care Med; 2021 Jan; 203(2):266-267. PubMed ID: 33022187
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacological management of breathlessness in COPD: recent advances and hopes for the future.
    O'Donnell DE; Webb KA; Harle I; Neder JA
    Expert Rev Respir Med; 2016 Jul; 10(7):823-34. PubMed ID: 27115291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of short-acting opioids in the management of breathlessness: an evidence-based review.
    Hui D; Bruera E
    Curr Opin Support Palliat Care; 2020 Sep; 14(3):167-176. PubMed ID: 32701856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reply to Vozoris: Opioids for Dyspnea in Chronic Obstructive Pulmonary Disease: Short on the Details.
    Mammen MJ; Charbek E; Alexander PE; Nici L; Aaron SD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):267-269. PubMed ID: 33022179
    [No Abstract]   [Full Text] [Related]  

  • 27. Barriers to Prescribing Opioids in the Management of Chronic Breathlessness in COPD: A Review.
    Keogh E; Williams EM
    COPD; 2021 Dec; 18(6):713-722. PubMed ID: 34761726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is chronic breathlessness less recognised and treated compared with chronic pain? A case-based randomised controlled trial.
    Ahmadi Z; Sandberg J; Shannon-Honson A; Vandersman Z; Currow DC; Ekström M
    Eur Respir J; 2018 Sep; 52(3):. PubMed ID: 30002106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Opioids in Patients With Chronic Obstructive Pulmonary Disease and Chronic Breathlessness.
    Widera EW
    JAMA Intern Med; 2020 Oct; 180(10):1315-1316. PubMed ID: 32804196
    [No Abstract]   [Full Text] [Related]  

  • 30. Nebulized morphine for the relief of dyspnea.
    Mabe SR; Connelly JF
    Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of Vaporized Cannabis on Exertional Breathlessness and Exercise Endurance in Advanced Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial.
    Abdallah SJ; Smith BM; Ware MA; Moore M; Li PZ; Bourbeau J; Jensen D
    Ann Am Thorac Soc; 2018 Oct; 15(10):1146-1158. PubMed ID: 30049223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Opioids for treating refractory dyspnea in patients with heart failure: A protocol for systematic review and meta-analysis: Retraction.
    Medicine (Baltimore); 2023 Jul; 102(27):e34401. PubMed ID: 37417643
    [No Abstract]   [Full Text] [Related]  

  • 33. A critical review of the respiratory benefits and harms of orally administered opioids for dyspnea management in COPD.
    Vozoris NT
    Expert Rev Respir Med; 2021 Dec; 15(12):1579-1587. PubMed ID: 34761704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need to address increasing opioid use in elderly COPD patients.
    Vozoris NT; O'Donnell DE
    Expert Rev Respir Med; 2016; 10(3):245-8. PubMed ID: 26783198
    [No Abstract]   [Full Text] [Related]  

  • 35. Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
    Luo N; Tan S; Li X; Singh S; Liu S; Chen C; Huang Z; Feng S; Lin Y; Lin Y; Cen H; Liang M; Chen M
    J Pain Symptom Manage; 2021 Jan; 61(1):198-210.e1. PubMed ID: 32730950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacological therapy of refractory dyspnoea : a systematic literature review].
    Simon ST; Köskeroglu P; Bausewein C
    Schmerz; 2012 Sep; 26(5):515-22. PubMed ID: 22956077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blinded Patient Preference for Morphine Compared to Placebo in the Setting of Chronic Refractory Breathlessness--An Exploratory Study.
    Ferreira DH; Silva JP; Quinn S; Abernethy AP; Johnson MJ; Oxberry SG; Currow DC
    J Pain Symptom Manage; 2016 Feb; 51(2):247-54. PubMed ID: 26598037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults.
    Simon ST; Higginson IJ; Booth S; Harding R; Weingärtner V; Bausewein C
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD007354. PubMed ID: 27764523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and management of chronic breathlessness in COPD in a tertiary care center.
    Carette H; Zysman M; Morelot-Panzini C; Perrin J; Gomez E; Guillaumot A; Burgel PR; Deslee G; Surpas P; Le Rouzic O; Perez T; Chaouat A; Roche N; Chabot F;
    BMC Pulm Med; 2019 May; 19(1):95. PubMed ID: 31096982
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of inhaled opioids and furosemide for the treatment of dyspnea.
    Kallet RH
    Respir Care; 2007 Jul; 52(7):900-10. PubMed ID: 17594733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.